Sjoerd H. van der Burg

3 articles listing Sjoerd H. van der Burg in Nature Communications, indexed by Paperzzz from Crossref and OSF.

1. IL-2 mutein-engrafted antibody MHS552 selectively expands functional regulatory T cells in nonclinical models and healthy participants Nature Communications
2. REACtiVe-2: phase I evaluation of dendritic cell vaccination and agonistic CD40 therapy following (m)FOLFIRINOX in metastatic pancreatic cancer Nature Communications
3. TEIPP-vaccination in checkpoint-resistant non-small cell lung cancer: a first-in-human phase I/II dose-escalation study Nature Communications